413 related articles for article (PubMed ID: 29310960)
1. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
Richards JR
J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
Richards JR
Med Hypotheses; 2017 Jun; 103():90-95. PubMed ID: 28571820
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
[No Abstract] [Full Text] [Related]
4. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
[TBL] [Abstract][Full Text] [Related]
5. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
Hernandez JM; Paty J; Price IM
CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.
Richards JR; Gordon BK; Danielson AR; Moulin AK
Pharmacotherapy; 2017 Jun; 37(6):725-734. PubMed ID: 28370228
[TBL] [Abstract][Full Text] [Related]
8. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
Witsil JC; Mycyk MB
Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
Kum V; Bell A; Fang W; VanWert E
Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
[TBL] [Abstract][Full Text] [Related]
11. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
Graham J; Barberio M; Wang GS
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome.
Geraci E; Cake C; Mulieri KM; Fenn NE
J Pediatr Pharmacol Ther; 2023; 28(3):222-227. PubMed ID: 37303765
[TBL] [Abstract][Full Text] [Related]
14. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
Richards JR; Lapoint JM; Burillo-Putze G
Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
Desjardins N; Jamoulle O; Taddeo D; Stheneur C
J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid hyperemesis syndrome: a review of the literature.
Deceuninck E; Jacques D
Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]